Showing results (1-10 of 339) with videos related to
Sort By:
Pageof 34
Expert Review of Molecular Diagnostics|May 27, 2014
Pharmacogenetic biomarkers for predicting drug responsePaul Christiaan Bank, Joachim Jesse Swen, Henk-Jan GuchelaarPharmacogenomics|September 11, 2008
Use of plasmid-derived external quality control samples in pharmacogenetic testingTahar van der Straaten, Jesse Swen, Renee Baak-Pablo, et al.Pharmacogenomics|June 27, 2015
Pharmacogenetics in electroconvulsive therapy and adjunctive medicationsHooman Mirzakhani, Martijn S van Noorden, Jesse Swen, et al.Pharmacogenetics and Genomics|August 1, 2015
Aberrant CYP2D6 metabolizer phenotypes do not show increased frequency in patients undergoing ECT after antidepressant therapyHooman Mirzakhani, Juliët van Dormolen, Karen van der Weide, et al.Frontiers in Immunology|July 5, 2022
Immunogenicity of Monoclonal Antibodies and the Potential Use of HLA Haplotypes to Predict Vulnerable PatientsRomy Mosch, Henk-Jan GuchelaarClinical and Translational Science|December 31, 2025
Pre-Therapeutic UGT1A1 Genotyping in Breast Cancer Patients Receiving Sacituzumab Govitecan to Improve Safety: A Meta-Analysis and RecommendationTessa Goedhart, Henk-Jan GuchelaarPharmaceuticals (Basel, Switzerland)|February 26, 2022
The Potential Application of Extracellular Vesicles from Liquid Biopsies for Determination of Pharmacogene ExpressionHenok D Habtemariam, Henk-Jan GuchelaarDrug Discovery Today|August 7, 2024
The efficacy and safety of eculizumab in patients and the role of C5 polymorphismsHendrikus Bernhard Bouwman, Henk-Jan GuchelaarPharmacy World & Science : PWS|July 5, 2003
Risk assessment in clinical pharmacyPatrick T Hudson, Henk-Jan GuchelaarPharmacy World & Science : PWS|July 5, 2003
The potential role of computerisation and information technology in improving prescribing in hospitalsHenk-Jan Guchelaar, Mathijs D KalmeijerPageof 34